FIELD: medicine.
SUBSTANCE: normalise level of products of transformation nitrogen oxide in the blood of patients with metabolic syndrome (MS). For this purpose within 2 months carry out the complex treatment including individually picked up hypohigh-calorie diet, rationally dosed out static and dynamic loadings, and also introduction of the 8 mg Kandesartan preparation 1 time in the morning.
EFFECT: risk decrease of thrombotic complications at patients with MS at the expense of normalisation of level of products of nitrogene oxide transformation in blood of patients with MS.
1 ex
Authors
Dates
2009-01-10—Published
2007-05-28—Filed